COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,952 Articles (22,604 medRxiv, 8,348 bioRxiv)

Most recent first Previous |  Page 2714: Articles 27131-27140  | Next

Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
Vanderheiden, A., Ralfs, P., Chirkova, T., Upadhyay, A. A., Zimmerman, M. G., Bedoya, S., Aoued, H., Tharp, G. K., Pellegrini, K., Lowen, A. C., Menachery, V. D., Anderson, L. J., Grakoui, A., Bosinger, S. E., Suthar, M. S.
10.1101/2020.05.19.105437 — Posted: 2020-05-20 Discussion: Onsite | Offsite
Discovery of potent inhibitors of PLproCoV2 by screening libraries of selen-containing compounds
Weglarz-Tomczak, E., Tomczak, J. M., Giurg, M., Burda-Grabowska, M.
10.1101/2020.05.20.107052 — Posted: 2020-05-20
Prediction of the virus incubation period for COVID-19 and future outbreaks
Gussow, A. B., Auslander, N., Wolf, Y. I., Koonin, E. V.
10.1101/2020.05.19.104513 — Posted: 2020-05-20
Tiger team: a panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
Noy-Porat, T., Makdasi, E., Alcalay, R., Mechaly, A., Levy, Y., Bercovich-Kinori, A., Zauberman, A., Tamir, H., Yahalom-Ronen, Y., Israeli, M., Epstein, E., Achdout, H., Melamed, S., Chitlaru, T., Weiss, S., Peretz, E., Rosen, O., Paran, N., Yitzhaki, S., Shapira, S. C., Israely, T., Mazor, O., Rosenfeld, R.
10.1101/2020.05.20.106609 — Posted: 2020-05-20
CONTAIN: An open-source shipping container laboratory optimisedfor automated COVID-19 diagnostics
Walker, K. T., Donora, M., Thomas, A., Phillips, A. J., Ramgoolam, K., Pilch, K. S., Oberacker, P., Jurkowski, T. P., Gosman, R. M., Fleiss, A., Perkins, A., MacKenzie, N., Zuckerman, M., Danovi, D., Steiner, H., Meany, T.
10.1101/2020.05.20.106625 — Posted: 2020-05-20
Asymptomatic COVID-19 Have Longer Treatment Cycle Than Moderate Type of Confirmed Patients
Zhang, W., Long, Q., Huang, Y., Chen, C., Wu, J., Hong, Y., Zhou, H., Wu, W.
10.1101/2020.05.16.20103796 — Posted: 2020-05-20
COVID-19 in Uganda: Predicting the impact of the disease and public health response on disease burden
BELL, D., Schultz Hansen, K., Kiragga, A. N., Kambugu, A., Kissa, J., Mbonye, A. K.
10.1101/2020.05.14.20102202 — Posted: 2020-05-20
People Behavior Changes in China during COVID-19 Pandemic
Wu, Y., Huang, M., Xie, G., Chen, X.
10.1101/2020.05.15.20097667 — Posted: 2020-05-20
Is Nigeria really on top of COVID-19? Message from effective reproduction number
Adekunle, A. I., Adegboye, O., Gayawan, E., McBryde, E.
10.1101/2020.05.16.20104471 — Posted: 2020-05-20
The potential impact of the COVID-19 pandemic on tuberculosis: a modelling analysis
Cilloni, L., Fu, H., Vesga, J. F., Dowdy, D., Pretorius, C., Ahmedov, S., Nair, S. A., Mosneaga, A., Masini, E. O., Suvanand, S., Arinaminpathy, N.
10.1101/2020.05.16.20104075 — Posted: 2020-05-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).